![David Jin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Jin
Amministratore Delegato presso
GenExosome Technologies, Inc.
Patrimonio netto: 29 973 $ in data 30/06/2026
Profilo
David K.
Jin is currently President, CEO, Director & Chief Medical Officer at GenExosome Technologies, Inc. since 2017.
Dr. Jin is also Chief Executive Officer & Director at Avalon Heathcare Systems, Inc. Formerly, Dr. Jin was President, Chief Executive Officer & Director at Avalon GloboCare Corp.
from 2016 to 2025.
Dr. Jin served as Chief Medical Officer at AdvisoryCloud, Inc. Dr. Jin was Chief Medical Officer at Lineage Cell Therapeutics, Inc. from 2009 to 2016.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2026 | 103.000 ( 0,85% ) | 29 973 $ | 30/06/2026 |
Posizioni attive di David Jin
| Società | Posizione | Inizio |
|---|---|---|
GenExosome Technologies, Inc.
 GenExosome Technologies, Inc. MiscellaneousMiscellaneous Operates as an investment holding company | Amministratore Delegato | 27/09/2017 |
Avalon Heathcare Systems, Inc. | Amministratore Delegato | - |
Precedenti posizioni note di David Jin
| Società | Posizione | Fine |
|---|---|---|
| AVALON GLOBOCARE CORP. | Amministratore Delegato | 30/11/2025 |
| LINEAGE CELL THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
AdvisoryCloud, Inc.
 AdvisoryCloud, Inc. Miscellaneous Commercial ServicesCommercial Services Provides ranking services for leading executives | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
30
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Avalon GloboCare Corp.
 Avalon GloboCare Corp. BiotechnologyHealth Technology Provides biotechnology and healthcare service | Health Technology |
AdvisoryCloud, Inc.
AdvisoryCloud, Inc. Miscellaneous Commercial ServicesCommercial Services Provides ranking services for leading executives | Commercial Services |
GenExosome Technologies, Inc.
GenExosome Technologies, Inc. MiscellaneousMiscellaneous Operates as an investment holding company | Miscellaneous |
Avalon Heathcare Systems, Inc. |
